Cargando…

The Impact of Compensation Gap on Corporate Innovation: Evidence from China’s Pharmaceutical Industry

The pharmaceutical industry is typically driven by innovation, and is relevant to people’s livelihoods. How to effectively motivate pharmaceutical enterprises to engage in innovative activities is a hot topic. On the basis of the perspective of the combined effect of tournament theory and social com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Liping, Zhang, Shan, Wu, Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835278/ https://www.ncbi.nlm.nih.gov/pubmed/35162779 http://dx.doi.org/10.3390/ijerph19031756

Ejemplares similares

Evolutionary Path and Innovative Development of Pharmaceutical Industrial Cluster—A Case Study of Shijiazhuang, China
por: Fu, Liping, et al.
Publicado: (2022)

The impact of executive compensation incentive on corporate innovation capability: Evidence from agro-based companies in China
por: Shang, Yue, et al.
Publicado: (2023)

The impact of industrial robot adoption on corporate green innovation in China
por: Liang, Lin, et al.
Publicado: (2023)

Transnational corporations in the pharmaceutical industry of developing countries.
Publicado: (1984)

Corporate social responsibility of pharmaceutical industry in Korea
por: Bae, Green, et al.
Publicado: (2022)

CEO Overconfidence and Corporate Innovation Outcomes: Evidence From China
por: Li, Zhongze, et al.
Publicado: (2022)

Regional intergenerational mobility and corporate innovation: Evidence from China
por: Luo, Changfu, et al.
Publicado: (2023)

Public preferences for corporate social responsibility activities in the pharmaceutical industry: Empirical evidence from Korea
por: Lee, Hankil, et al.
Publicado: (2019)

Measure on innovation efficiency of China's pharmaceutical manufacturing industry
por: Zhong, Shen, et al.
Publicado: (2022)

The Impact of Corporate Social Responsibility on Sustainable Innovation: A Case in China’s Heavy Pollution Industry
por: Yan, Rui, et al.
Publicado: (2022)

Regional technology gap and innovation efficiency trap in Chinese pharmaceutical manufacturing industry
por: Lai, Hongbo, et al.
Publicado: (2020)

Impact of Corporate Governance on Research and Development Investment in the Pharmaceutical Industry in South Korea
por: Lee, Munjae
Publicado: (2015)

Strategic orientation, business model innovation and corporate performance—Evidence from construction industry
por: Han, Wucheng, et al.
Publicado: (2022)

Stock Market Liberalization and Corporate Green Innovation: Evidence from China
por: Zhang, Yuming, et al.
Publicado: (2021)

Synergy effect of talent policies on corporate innovation—Evidence from China
por: Chen, Qiuling, et al.
Publicado: (2023)

Independent research and development, technology accumulation and innovation performance: Evidence from China’s pharmaceutical manufacturing industry
por: Wang, Su, et al.
Publicado: (2022)

The Effect of Corporate Social Responsibility and Public Attention on Innovation Performance: Evidence from High-polluting Industries
por: Wang, Wei, et al.
Publicado: (2019)

Does real estate bubble affect corporate innovation? Evidence from China
por: Wang, Chen, et al.
Publicado: (2021)

Local governments’ environmental emphasis and corporate green innovation: evidence from China
por: Zhao, Yueyang, et al.
Publicado: (2022)

Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies
por: Zhu, Jialin, et al.
Publicado: (2023)

Government innovation subsidy, executives’ academic capital and innovation quality: Evidence from pharmaceutical companies in China
por: Xia, Yuntian, et al.
Publicado: (2023)

Green Innovation, Corporate Environmental Ethics, and Competitive Advantages of Chinese Automobile Industry During COVID-19: Corporate Environmental Management as Moderator
por: Wu, Wenhan, et al.
Publicado: (2022)

Digital Economy, Environmental Regulation and Corporate Green Technology Innovation: Evidence from China
por: Wang, Chenggang, et al.
Publicado: (2022)

Does green credit policy promote corporate green innovation? Evidence from China
por: Yin, Xiwen, et al.
Publicado: (2023)

The Impact of Environmental Uncertainty on Corporate Innovation: Empirical Evidence from an Emerging Economy
por: Chen, Jinyong, et al.
Publicado: (2021)

Intra-industry peer effect in corporate environmental information disclosure: Evidence from China
por: Hu, Kewei, et al.
Publicado: (2022)

The impact of economic policy uncertainty on corporate social responsibility: A new evidence from food industry in China
por: Su, Fang, et al.
Publicado: (2022)

Corporate Digital Transformation and Green Innovation: A Quasi-Natural Experiment from Integration of Informatization and Industrialization in China
por: Zhang, Qincheng, et al.
Publicado: (2022)

How Technological Innovation Affect China's Pharmaceutical Smart Manufacturing Industrial Upgrading
por: Wang, Su, et al.
Publicado: (2021)

Does Employee Care Trigger Innovation Under a Healthy and Safe Working Environment? Evidence from the Pharmaceutical Industry in China
por: Yang, Minghui, et al.
Publicado: (2021)

Environmental cooperation system, ESG performance and corporate green innovation: Empirical evidence from China
por: Qiang, Shi, et al.
Publicado: (2023)

Effects of Pandemics on Corporate Innovation: Evidence From the Chinese Firms
por: Zhang, Ci, et al.
Publicado: (2021)

The impact of corporate digital strategic orientation on innovation output
por: Fan, Xueyuan, et al.
Publicado: (2023)

The impact of subscribing to directors’ and officers’ liability insurance on corporate financialization: Evidence from China
por: Peng, Cheng, et al.
Publicado: (2022)

Health assessment of innovative ecological rainforest in pharmaceutical industry: Case study of Zhejiang, China
por: Dong, Ying, et al.
Publicado: (2023)

Financing innovation and enterprises’ efficiency of technological innovation in the internet industry: Evidence from China
por: Piao, Zhefan, et al.
Publicado: (2020)

Causal Relationships among Technology Acquisition, Absorptive Capacity, and Innovation Performance: Evidence from the Pharmaceutical Industry
por: Jeon, Jieun, et al.
Publicado: (2015)

The Impact of Digital Transformation on Corporate Environment Performance: Evidence from China
por: Wang, Lei, et al.
Publicado: (2022)

How does venture capital cross-border syndication spur corporate innovation? Evidence from China
por: Hao, Haixia, et al.
Publicado: (2022)

Chief Executive Officer Collectivism and Corporate Pollution Abatement Behavior: Evidence From Industrial Firms in China
por: Wang, Shumin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aep2m0klj0la7pvcs7au74lfsm